Butazolidina 20%

Butazolidine 20%; DESCRIPTION; : An injectable anti-inflammatory and analgesic formulation based on phenylbutazone; COMPOSITION; Phenylbutazone: 20 g; Excipients q.s.: 100 ml; ACTION; Analgesic. Nonsteroidal anti-inflammatory drug; INDICATIONS; Acute and chronic inflammatory conditions. Arthritis. Myositis. Tendinitis. Synovitis. Joint strain. Osteitis. Hyperthermia; CONTRAINDICATIONS AND WARNINGS; Do not use in combination with warfarin or sulfonamides. Do not use if gastrointestinal ulcers, coagulation disorders, cardiac, renal, or hepatic dysfunction are suspected, or if the thyroid glands are affected, or in cases of allergy to this drug; In case of acute toxicity caused by the medication, discontinue treatment, alkalinize the urine, and administer prostaglandins; Since the product will be used under circumstances beyond the manufacturer’s control, the manufacturer assumes no liability for consequences arising from its improper use; DOSAGE; Administer exclusively by slow intravenous injection; In adult horses: the loading dose is 4 ml per day per 100 kg, and the maintenance dose is 2.5 to 3 ml per 100 kg; Ponies and elderly animals: 2.2 mg/kg/day; PACKAGING; : 100-ml vial; ADMINISTRATION; Injectable